Trial Profile
Dose Escalation Study of Liposomal Paclitaxel in Chinese Patients With Advanced Solid Tumors.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Mar 2010
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Nanjing Sike Pharmaceutical
- 27 Apr 2009 New trial record